Stocks and InvestingStocks and Investing
Thu, June 6, 2024
Wed, June 5, 2024
Tue, June 4, 2024
Mon, June 3, 2024

Tejas Savant Maintained (AKYA) at Buy with Decreased Target to $4 on, Jun 3rd, 2024


Published on 2024-10-28 11:45:49 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $8 to $4 on, Jun 3rd, 2024.

Tejas has made no other calls on AKYA in the last 4 months.



There are 4 other peers that have a rating on AKYA. Out of the 4 peers that are also analyzing AKYA, 0 agree with Tejas's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Tejas


  • Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, May 14th, 2024
  • Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, May 14th, 2024
  • Rachel Vatnsdal of "JP Morgan" Maintained at Buy with Decreased Target to $10 on, Wednesday, March 6th, 2024
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $7.5 on, Tuesday, March 5th, 2024